Sun Pharma and SPARC sign a licence contract for the sale of phenobarbital
Sun Pharma Advanced Research Co. and Sun Pharmaceutical Industries Ltd. Ltd (SPARC) reported on Wednesday that the businesses had signed a licencing agreement for the commercialization of phenobarbital for injection in the US. In February 2022, SPARC submitted a New Drug Application (NDA) for this medicine to the US Food and Drug Administration (USFDA). The